GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » Shiller PE Ratio

Perspective Therapeutics (FRA:AAJ) Shiller PE Ratio : (As of May. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Perspective Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Perspective Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Shiller PE Ratio Chart

Perspective Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Perspective Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Perspective Therapeutics's Shiller PE Ratio

For the Medical Devices subindustry, Perspective Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perspective Therapeutics's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's Shiller PE Ratio falls into.



Perspective Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Perspective Therapeutics's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Perspective Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.018/131.7762*131.7762
=-0.018

Current CPI (Mar. 2024) = 131.7762.

Perspective Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.022 100.560 -0.029
201409 -0.008 100.428 -0.010
201412 -0.016 99.070 -0.021
201503 -0.018 99.621 -0.024
201506 -0.018 100.684 -0.024
201509 -0.018 100.392 -0.024
201512 -0.018 99.792 -0.024
201603 -0.018 100.470 -0.024
201606 -0.027 101.688 -0.035
201609 -0.027 101.861 -0.035
201612 -0.028 101.863 -0.036
201703 -0.023 102.862 -0.029
201706 -0.027 103.349 -0.034
201709 -0.025 104.136 -0.032
201712 -0.025 104.011 -0.032
201803 -0.020 105.290 -0.025
201806 -0.036 106.317 -0.045
201809 -0.017 106.507 -0.021
201812 -0.018 105.998 -0.022
201903 -0.018 107.251 -0.022
201906 -0.018 108.070 -0.022
201909 -0.009 108.329 -0.011
201912 -0.009 108.420 -0.011
202003 -0.009 108.902 -0.011
202006 -0.018 108.767 -0.022
202009 -0.008 109.815 -0.010
202012 -0.008 109.897 -0.010
202103 -0.008 111.754 -0.009
202106 -0.008 114.631 -0.009
202109 -0.017 115.734 -0.019
202112 -0.009 117.630 -0.010
202203 -0.009 121.301 -0.010
202206 -0.009 125.017 -0.009
202209 -0.030 125.227 -0.032
202212 -0.019 125.222 -0.020
202303 0.000 127.348 0.000
202306 -0.037 128.729 -0.038
202309 -0.037 129.860 -0.038
202312 -0.083 129.419 -0.085
202403 -0.018 131.776 -0.018

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perspective Therapeutics  (FRA:AAJ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Perspective Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perspective Therapeutics (FRA:AAJ) Business Description

Traded in Other Exchanges
Address
350 Hills Street, Suite 106, Richland, WA, USA, 99354
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines